RT Journal Article
T1 Vitamin D Status in Pediatric and Young Adult Cystic Fibrosis Patients. Are the New Recommendations Effective?
A1 Mangas-Sanchez, Carmen
A1 Garriga-Garcia, Maria
A1 Serrano-Nieto, Maria Juliana
A1 Garcia-Romero, Ruth
A1 alvarez-Beltran, Marina
A1 Crehua-Gaudiza, Elena
A1 Munoz-Codoceo, Rosana
A1 Suarez-Cortina, Lucrecia
A1 Vicente-Santamaria, Saioa
A1 Martinez-Costa, Cecilia
A1 Diaz-Martin, Juan Jose
A1 Bousono-Garcia, Carlos
A1 Gonzalez-Jimenez, David
K1 vitamin D
K1 cystic fibrosis
K1 multicenter study
K1 D insufficiency
K1 D deficiency
K1 Children
K1 Cholecalciferol
K1 Ergocalciferol
AB Introduction: In recent years, guidelines for vitamin D supplementation have been updated and prophylactic recommended doses have been increased in patients with cystic fibrosis (CF). Objective: To evaluate safety and efficacy of these new recommendations. Results: Two cohorts of pancreatic insufficient CF patients were compared before (cohort 1: 179 patients) and after (cohort 2: 71 patients) American CF Foundation and European CF Society recommendations were published. Cohort 2 patients received higher Vitamin D doses: 1509 (1306-1711 95% CI) vs 1084 (983-1184 95% CI) IU/Day (p
PB Mdpi
YR 2021
FD 2021-12-01
LK https://hdl.handle.net/10668/24437
UL https://hdl.handle.net/10668/24437
LA en
DS RISalud
RD Apr 6, 2025